Stock Events

Stock Events

AEON Biopharma 

$0.2943
44
-$0.02-6.33% 14:31 Today

Statistics

Day High
0.31
Day Low
0.2942
52W High
1.45
52W Low
0.177
Volume
305,071
Avg. Volume
2,575,833
Mkt Cap
14.68M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-13.68
-7.87
-2.06
3.75
Expected EPS
-0.08
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-39.22MNet Income

Analyst Ratings

1.20Average Price Target
The highest estimate is 1.20.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AEON. It's not an investment recommendation.
NVIDIA
8
NVDA
Amazon
7
AMZN
AMD
6
AMD
Realty Income
5
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Evolus
EOLS
Mkt Cap586.53M
Evolus directly competes with AEON Biopharma in the aesthetic and therapeutic botulinum toxin products sector.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, through its acquisition of Allergan, competes in the botulinum toxin market, particularly in therapeutic areas.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. competes in the broader pharmaceuticals market, including areas that overlap with AEON Biopharma's focus.
Pfizer
PFE
Mkt Cap159.36B
Pfizer competes in the pharmaceuticals sector, including development of products that could compete with AEON Biopharma's offerings.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb competes in the pharmaceutical industry, potentially overlapping with AEON Biopharma's therapeutic areas.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline competes in the pharmaceutical and healthcare sector, including areas relevant to AEON Biopharma's market.
Novartis
NVS
Mkt Cap292.35B
Novartis competes in the global healthcare market, including in therapeutic areas that may overlap with AEON Biopharma's focus.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson competes across the healthcare spectrum, including pharmaceuticals that could compete with AEON Biopharma's products.

About

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Show more...
CEO
Robert Bancroft
Employees
8
Country
United States
ISIN
US00791X2099

Listings

XASE
US
AEON
BOATS
BOATS
AEON.BOATS

0 Comments

Share your thoughts

FAQ

What is AEON Biopharma stock price today?▼
The current price of AEON is $0.29 USD — it has decreased by -6.33% in the past 24 hours. Watch AEON Biopharma stock price performance more closely on the chart.
What is AEON Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange AEON Biopharma stocks are traded under the ticker AEON.
Is AEON Biopharma stock price growing?▼
AEON stock has risen by +56.23% compared to the previous week, the month change is a +5.26% rise, over the last year AEON Biopharma has showed a -57.85% decrease.
What is AEON Biopharma market cap?▼
Today AEON Biopharma has the market capitalization of 14.68M
When is the next AEON Biopharma earnings date?▼
AEON Biopharma is going to release the next earnings report on November 18, 2026.
What were AEON Biopharma earnings last quarter?▼
AEON earnings for the last quarter are -0.02 USD per share, whereas the estimation was -0.23 USD resulting in a +91.11% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is AEON Biopharma revenue for the last year?▼
AEON Biopharma revenue for the last year amounts to 0 USD.
What is AEON Biopharma net income for the last year?▼
AEON net income for the last year is -39.22M USD.
How many employees does AEON Biopharma have?▼
As of August 31, 2026, the company has 8 employees.
In which sector is AEON Biopharma located?▼
AEON Biopharma operates in the Health & Wellness sector.
When did AEON Biopharma complete a stock split?▼
The last stock split for AEON Biopharma was on February 26, 2025 with a ratio of 1:72.
Where is AEON Biopharma headquartered?▼
AEON Biopharma is headquartered in ALISO VIEJO, United States.